- Home
- ABVC vs CSCI Comparison
ABVC vs CSCI Comparison
Compare ABVC & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- CSCI
- Stock Information
- Founded
- ABVC 2015
- CSCI 1990
- Country
- ABVC United States
- CSCI Canada
- Employees
- ABVC N/A
- CSCI N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- ABVC Health Care
- CSCI
- Exchange
- ABVC Nasdaq
- CSCI NYSE
- Market Cap
- ABVC 12.8M
- CSCI 11.1M
- IPO Year
- ABVC N/A
- CSCI 1996
- Fundamental
- Price
- ABVC $0.54
- CSCI $3.00
- Analyst Decision
- ABVC
- CSCI
- Analyst Count
- ABVC 0
- CSCI 0
- Target Price
- ABVC N/A
- CSCI N/A
- AVG Volume (30 Days)
- ABVC 150.8K
- CSCI 9.5K
- Earning Date
- ABVC 03-12-2025
- CSCI 11-12-2024
- Dividend Yield
- ABVC N/A
- CSCI N/A
- EPS Growth
- ABVC N/A
- CSCI N/A
- EPS
- ABVC N/A
- CSCI N/A
- Revenue
- ABVC $509,788.00
- CSCI $4,834,000.00
- Revenue This Year
- ABVC N/A
- CSCI N/A
- Revenue Next Year
- ABVC N/A
- CSCI N/A
- P/E Ratio
- ABVC N/A
- CSCI N/A
- Revenue Growth
- ABVC N/A
- CSCI N/A
- 52 Week Low
- ABVC $0.41
- CSCI $2.50
- 52 Week High
- ABVC $1.73
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- ABVC 47.67
- CSCI N/A
- Support Level
- ABVC $0.50
- CSCI N/A
- Resistance Level
- ABVC $0.58
- CSCI N/A
- Average True Range (ATR)
- ABVC 0.06
- CSCI 0.00
- MACD
- ABVC -0.01
- CSCI 0.00
- Stochastic Oscillator
- ABVC 20.63
- CSCI 0.00
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.